KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Johnson & Johnson (JNJ) Cost of Revenue (2016 - 2025)

Johnson & Johnson's Cost of Revenue history spans 17 years, with the latest figure at $8.0 billion for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 11.78% year-over-year to $8.0 billion; the TTM value through Dec 2025 reached $30.3 billion, up 10.14%, while the annual FY2025 figure was $30.3 billion, 10.14% up from the prior year.
  • Cost of Revenue for Q4 2025 was $8.0 billion at Johnson & Johnson, up from $7.3 billion in the prior quarter.
  • Across five years, Cost of Revenue topped out at $8.2 billion in Q3 2023 and bottomed at $2.7 billion in Q1 2023.
  • The 5-year median for Cost of Revenue is $7.2 billion (2021), against an average of $7.0 billion.
  • The largest annual shift saw Cost of Revenue soared 152.15% in 2023 before it decreased 16.35% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $7.3 billion in 2021, then fell by 14.87% to $6.2 billion in 2022, then rose by 10.14% to $6.8 billion in 2023, then increased by 4.85% to $7.1 billion in 2024, then rose by 11.78% to $8.0 billion in 2025.
  • Per Business Quant, the three most recent readings for JNJ's Cost of Revenue are $8.0 billion (Q4 2025), $7.3 billion (Q3 2025), and $7.6 billion (Q2 2025).